Why?
The main reason is that the FDA hasn't given a decision on the
approving the drug Provenge. It is purely speculations at this point
whether the stock "DNDN" will go up. To my best opinion, Mr. Warren
Buffet would never be interested in such a company that the FDA
hasn't
place an approve label on it.
Free complete research on Dendreon can be found at:
http://www.1pennystock.com/dendreon/